PE/TR Anti-Human CD19 Antibody[CB19]

Introducing the PE/TR Anti-Human CD19 Antibody [CB19], a cutting-edge product designed to revolutionize the field of immunology. This antibody, meticulously developed by our team of experts, exhibits exceptional specificity and affinity towards the CD19 antigen, making it an invaluable tool for various research applications.

The PE/TR Anti-Human CD19 Antibody [CB19] is meticulously manufactured using state-of-the-art techniques, ensuring the highest level of quality and consistency. Its unique composition allows for precise and reliable detection of CD19 expression on human cells, enabling researchers to gain deeper insights into the role of CD19 in various biological processes.

With its dual labeling capability, this antibody offers the convenience of simultaneous detection of CD19 expression using both PE and TR fluorochromes. This feature not only saves valuable time but also enhances experimental efficiency, making it an ideal choice for high-throughput screening and multiplex assays.

Furthermore, the PE/TR Anti-Human CD19 Antibody [CB19] demonstrates exceptional performance in flow cytometry, providing accurate and reproducible results. Its superior sensitivity and low background noise ensure reliable detection of even low-abundance CD19-positive cells, facilitating precise characterization and enumeration of specific cell populations.

In addition to its exceptional performance, this antibody boasts excellent stability, allowing for long-term storage without compromising its functionality. Its robustness and reliability make it an indispensable tool for long-term studies and large-scale experiments.

The PE/TR Anti-Human CD19 Antibody [CB19] is meticulously validated through rigorous quality control procedures, ensuring its consistent performance across different batches. Its compliance with stringent industry standards guarantees reliable and reproducible results, instilling confidence in researchers and facilitating seamless integration into their experimental workflows.

In summary, the PE/TR Anti-Human CD19 Antibody [CB19] represents a breakthrough in immunological research, offering exceptional specificity, dual labeling capability, superior performance in flow cytometry, excellent stability, and meticulous validation. With its unparalleled features, this antibody is poised to revolutionize the field and empower researchers to unravel the complexities of CD19 biology with unprecedented precision and accuracy.